Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A diabetes drug that showed promise in previous studies as an anti-cancer treatment failed to show any benefit in a UNC Lineberger Comprehensive Cancer Center-led study that used pancreatic cancer tissue samples to test sensitivity to the drug.
The study, published in the journal PLOS ONE, supports findings from a randomized clinical trial published last year. That previous study, published in The Lancet Oncology, found no improved outcomes for pancreatic cancer patients who added the type 2 diabetes drug metformin to cancer treatment.
http://www.sciencedaily.com/releases/2016/01/160119143231.htm
Perhaps not such a superdrug? 🙄
The study, published in the journal PLOS ONE, supports findings from a randomized clinical trial published last year. That previous study, published in The Lancet Oncology, found no improved outcomes for pancreatic cancer patients who added the type 2 diabetes drug metformin to cancer treatment.
http://www.sciencedaily.com/releases/2016/01/160119143231.htm
Perhaps not such a superdrug? 🙄
